SCHEMBL13097570

SCHEMBL13097570

Cc1c(COc2cccc(OCC3CCOCC3)c2)[nH]c2ccc(F)cc2c1=O

nearest known ligand 0.79

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2D6 P10635 8/20 0.79
MAPK1 P28482 1/20 0.39
MAOA P21397 1/20 0.39
ACHE P22303 1/20 0.39
MAOB P27338 1/20 0.39
DRD2 P14416 2/20 0.38
SLC6A4 P31645 2/20 0.38
HTR2B P41595 1/20 0.38
PDE3B Q13370 1/20 0.37
PDE3A Q14432 1/20 0.37
NOS3 P29474 1/20 0.36
NOS1 P29475 1/20 0.36
NOS2 P35228 1/20 0.36
HTR6 P50406 1/20 0.35
KDM4E B2RXH2 3/20 0.35
ALDH1A1 P00352 2/20 0.35
HTT P42858 2/20 0.35
BRD4 O60885 1/20 0.35
LMNA P02545 1/20 0.35
MAPT P10636 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13097604 0.92 CYP2D6 (0.68) CYP2D6MAPK1MAOAACHEMAOB
SCHEMBL13097617 0.91 CYP2D6 (0.66) CYP2D6MAPK1MAOAACHEMAOB
SCHEMBL13097573 0.91 CYP2D6 (0.82) CYP2D6MAOAMAOBPDE3BPDE3A
SCHEMBL13097574 0.89 CYP2D6 (0.79) CYP2D6MAOAACHEMAOBPDE3B
SCHEMBL13097571 0.89 CYP2D6 (0.79) CYP2D6MAOAMAOBPDE3BPDE3A
SCHEMBL13097576 0.89 CYP2D6 (0.79) CYP2D6MAOAMAOBPDE3BPDE3A
SCHEMBL3101982 0.89 CYP2D6 (1.00) CYP2D6PDE3BPDE3ANOS3NOS1
SCHEMBL3106719 0.88 CYP2D6 (0.61) CYP2D6MAPK1MAOAACHEMAOB
SCHEMBL13097967 0.86 CYP2D6 (0.75) CYP2D6PDE3BPDE3AKDM4EALDH1A1
SCHEMBL13097594 0.86 CYP2D6 (0.84) CYP2D6KDM4EHTTBRD4LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8367702-B2 Quinolone derivative ASTELLAS PHARMA INC. (JP) 2013-02-05 US disclosed
US-8367702-B2 Quinolone derivative ASTELLAS PHARMA INC. (JP) 2013-02-05 US disclosed
US-20100256113-A1 QUINOLONE DERIVATIVE ASTELLAS PHARMA INC. (JP) 2010-10-07 US disclosed
US-20100256113-A1 QUINOLONE DERIVATIVE ASTELLAS PHARMA INC. (JP) 2010-10-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100256113-A1 QUINOLONE DERIVATIVE NQO1, NQO2, NADK CYP2D6 230/4885MAPK1 1589/4885MAOA 128/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.